Malignant hyperthermia and the dilemma of Dantrolene’s unavailability: a case report
Journal of the Pakistan Medical Association · 2025
DOI: 10.47391/jpma.21382 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of the Pakistan Medical Association, 2025. Verfasst von Abdullah Mahmood und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Plastic Surgery and Burn Unit, Ayub Teaching Hospital, Abbottabad, Pakistan. Hauptthemen laut MEDLINE: Malignant Hyperthermia, Dantrolene, Muscle Relaxants, Central. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Malignant Hyperthermia (MH) is a rare disorder which is triggered in genetically susceptible individuals when exposed to non-depolarising muscle relaxant (Succinylcholine) and inhalational anaesthetics (Isoflurane, Desflurane, Sevoflurance, Halothane, etc.). If not treated promptly, it carries a significantly high mortality rate. The only approved drug for the treatment of MH is Dantrolene, which is not available in Pakistan and its availability in other countries is also limited. We encountered a case of MH on January 3, 2024, in a five-year-old girl during her recovery from general anaesthesia after undergoing Tenotomy of Flexor Digitorum Superficialis (FDS) tendon for her Camptodactyly. Isoflurane was used for the maintenance of anaesthesia. The patient developed high grade fever and muscle rigidity in her limbs during recovery from anaesthesia. Supportive treatment was started promptly and the patient was immediately shifted to the ICU from the recovery room. Unfortunately, due to unavailability of Dantrolene the patient did not survive the event despite rigorous attempts at resuscitation. Keywords: Malignant Hyperthermia, Dantrolene, Camptodactyly.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Plastic Surgery and Burn Unit, Ayub Teaching Hospital, Abbottabad, Pakistan.
- Department of Anaesthesia, Ayub Teaching Hospital, Abbottabad, Pakistan.
Zitieren
APA
Mahmood, A., Abbasi, M. F., Shafiq, L., Khan, S., Mahmood, M., & Mehmood, S. M. (2025). Malignant hyperthermia and the dilemma of Dantrolene’s unavailability: a case report. Journal of the Pakistan Medical Association. https://doi.org/10.47391/jpma.21382
Vancouver
Mahmood A, Abbasi MF, Shafiq L, Khan S, Mahmood M, Mehmood SM. Malignant hyperthermia and the dilemma of Dantrolene’s unavailability: a case report. Journal of the Pakistan Medical Association. 2025. doi:10.47391/jpma.21382
BibTeX
@article{Mahmood2025,
author = {Mahmood, Abdullah and Abbasi, Muhammad Faizan and Shafiq, Lubna and Khan, Sumiya and Mahmood, Muaaz and Mehmood, Saqib Mehmood},
title = {Malignant hyperthermia and the dilemma of Dantrolene’s unavailability: a case report},
journal = {Journal of the Pakistan Medical Association},
year = {2025},
doi = {10.47391/jpma.21382}
}
EUVIMED